Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren.
Lebanon
PCSK9
cholesterol
dyslipidemia
lipoprotein (a)
pediatric
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
31 May 2022
31 May 2022
Historique:
received:
26
04
2022
revised:
17
05
2022
accepted:
24
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
In adults, elevated levels of circulating Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) have been associated with increased Low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and worse cardiovascular outcomes. However, few studies analyzed the relation between PCSK9 and lipid parameters in pediatric populations. The aim of our study is to evaluate the distribution and the correlation of serum PCSK9 levels with lipid parameters in a sample of Lebanese school children. Using an immunofluorescence assay, we measured serum PCSK9 levels in 681 school children recruited from ten public and private Lebanese schools. We analyzed the association between PCSK9 and age, sex, Body Mass Index (BMI), and lipid parameters (total cholesterol (TC), LDL-C, TG, High-density lipoprotein cholesterol (HDL-C), non-HDL-C, and lipoprotein (a) (Lp(a)). Serum PCSK9 levels were significantly correlated with TC, LDL-C, and non-HDL-C (p value < 0.0001) but not with TG, HDL-C, and Lp(a). PCSK9 levels were also significantly higher in children with high TC, LDL-C, and non-HDL-C (p values = 0.0012, 0.0002, 0.001, respectively). No significant gender differences in PCSK9 were found. In addition, no significant associations between PCSK9 and both age and BMI percentiles were observed. In girls, no difference in PCSK9 values was observed according to menarche while in boys, testosterone levels were not significantly associated with PCSK9. Serum PCSK9 levels were significantly correlated with TC, LDL-C, and non-HDL-C levels. Further studies are needed to find if PCSK9 measurements have an additional value to predict future cardiovascular outcomes in pediatric populations.
Identifiants
pubmed: 35736437
pii: metabo12060504
doi: 10.3390/metabo12060504
pmc: PMC9230653
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Saint Joseph University
ID : FM258 and FM380
Références
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Nutr Metab (Lond). 2013 Jan 08;10(1):4
pubmed: 23298392
Circulation. 2016 Mar 29;133(13):1230-9
pubmed: 26896437
Sci Rep. 2020 Nov 26;10(1):20620
pubmed: 33244019
J Am Coll Cardiol. 2018 Jul 17;72(3):314-329
pubmed: 30012326
Curr Atheroscler Rep. 2014 Sep;16(9):439
pubmed: 25052769
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
JAMA. 2003 Nov 5;290(17):2277-83
pubmed: 14600186
Clin Chem. 2007 Oct;53(10):1814-9
pubmed: 17702855
Atherosclerosis. 2016 Sep;252:50-60
pubmed: 27501130
Int J Pediatr Adolesc Med. 2019 Sep;6(3):101-108
pubmed: 31700968
Cardiol Clin. 2018 May;36(2):287-298
pubmed: 29609758
J Clin Endocrinol Metab. 2009 Jul;94(7):2537-43
pubmed: 19351729
J Clin Lipidol. 2011 Jun;5(3 Suppl):S9-17
pubmed: 21600530
Atherosclerosis. 2020 Sep;309:39-46
pubmed: 32862087
J Clin Endocrinol Metab. 2008 Nov;93(11):4200-9
pubmed: 18697860
Circulation. 2019 Mar 26;139(13):e603-e634
pubmed: 30798614
Pediatrics. 2011 Sep;128(3):463-70
pubmed: 21807697
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):237-245
pubmed: 31236571
Nat Genet. 2003 Jun;34(2):154-6
pubmed: 12730697
Ann Med. 2015;47(5):386-93
pubmed: 26153823
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
Endocrinology. 2009 Mar;150(3):1140-6
pubmed: 19008317
Clin Chem. 2009 Sep;55(9):1637-45
pubmed: 19628659
JAMA. 2009 Jul 22;302(4):412-23
pubmed: 19622820
Front Cardiovasc Med. 2021 Mar 23;8:639727
pubmed: 33834043
Lipids Health Dis. 2019 Feb 11;18(1):48
pubmed: 30744653
Circ Res. 2018 May 11;122(10):1420-1438
pubmed: 29748367
J Am Heart Assoc. 2017 May 3;6(5):
pubmed: 28468788
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):810-4
pubmed: 22207727
Pediatrics. 2008 May;121(5):924-9
pubmed: 18450895
J Lipid Res. 2016 Apr;57(4):697-705
pubmed: 26828068
Circulation. 2013 Jun 18;127(24):2403-13
pubmed: 23690465
J Lipid Res. 2012 May;53(5):979-983
pubmed: 22375030
J Am Heart Assoc. 2013 Apr 24;2(2):e000028
pubmed: 23537802
Ann Biol Clin (Paris). 1999 Nov-Dec;57(6):697-703
pubmed: 10572218
JAMA. 2021 Jul 27;326(4):352-353
pubmed: 34236417
Clin Chim Acta. 2015 Jun 15;446:97-104
pubmed: 25858546
J Clin Lipidol. 2016 Mar-Apr;10(2):378-85
pubmed: 27055969
Circ Res. 2016 Jun 24;119(1):29-35
pubmed: 27121620
J Lipid Res. 2015 Feb;56(2):463-9
pubmed: 25535288
Pediatrics. 2007 Jul;120(1):e189-214
pubmed: 17606543
Clin Biochem Rev. 2018 Aug;39(3):65-76
pubmed: 30828113
N Engl J Med. 2009 Dec 24;361(26):2518-28
pubmed: 20032323
Diabete Metab. 1990 Sep-Oct;16(5):435-40
pubmed: 2073969
Am J Epidemiol. 1991 May 1;133(9):884-99
pubmed: 2028978
Clin Chem. 2008 Jun;54(6):1038-45
pubmed: 18436719
Diabetes Obes Metab. 2018 Apr;20(4):943-953
pubmed: 29205760
Diabetes Metab Syndr Obes. 2019 Dec 31;12:2791-2797
pubmed: 32021342